Evidence map›Paper›PMID 38564687›Full record

ArticlemBio2024

Differential impacts of DNA repair machinery on fluoroquinolone persisters with different chromosome abundances.

Juechun Tang, Allison M Herzfeld, Gabrielle Leon, Mark P Brynildsen

Open access · goldAbstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Molecular Basis of Persister Awakening and Lag-Phase Recovery inInternational journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Juechun Tang *Department of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, USA.
Allison M Herzfeld *Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.ORCID 0000-0001-6362-2892
Gabrielle LeonDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, USA.ORCID 0009-0005-0912-5795
Mark P BrynildsenDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, USA.ORCID 0000-0001-5707-8894
Princeton University · USRutgers, The State University of New Jersey · US

Funding

Examining fluoroquinolone-induced DNA damage in persisters and its contributions to antibiotic resistance.R01AI130293 · NIAID · PRINCETON UNIVERSITY · PI BRYNILDSEN, MARK P · 2017 to 2021
$2.0M
Investigating ploidy modulation as a strategy to improve antibiotic activityR21AI182745 · NIAID · PRINCETON UNIVERSITY · PI BRYNILDSEN, MARK P · 2024 to 2025
$450k
Elucidating repair processes central to fluoroquinolone persistence in growth-inhibited populationsF30AI140697 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI HERZFELD, ALLISON · 2019 to 2023
$241k
NIAID NIH HHS F30 AI140697NIAID NIH HHS R01 AI130293NIAID NIH HHS R21 AI182745
6 · The paper itself

Abstract

DNA repair machinery has been found to be indispensable for fluoroquinolone (FQ) persistence of IMPORTANCE: Persisters are rare phenotypic variants in isogenic populations that survive antibiotic treatments that kill the other cells present. Evidence has accumulated that supports a role for persisters in chronic and recurrent infections. Here, we explore how an under-appreciated phenotypic variable, chromosome copy number (#Chr), influences the DNA repair systems persisters use to survive fluoroquinolone treatments. We found that #Chr significantly biases the DNA repair systems used by persisters, which suggests that #Chr heterogeneity should be considered when devising strategies to eradicate these troublesome bacterial variants.

Indexed as

Anti-Bacterial AgentsChromosomes, BacterialDNA RepairEscherichia coliEscherichia coli ProteinsFluoroquinolonesDrug Resistance, BacterialMicrobial Sensitivity TestsAnti-Bacterial AgentsEscherichia coli ProteinsFluoroquinolonesciprofloxacinlevofloxacinlexApersistencerecNuvrDxseAxseB

Identifiers

PMID38564687
PMCPMC11077951
OpenAlexW4393570456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.